1-5 of 5
Gregory A. Daniels
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible

Open Access
Taylor J. Jensen, Aaron M. Goodman, Christopher K. Ellison, Kimberly A. Holden, Shumei Kato, Lisa Kim, Gregory A. Daniels, Kerry Fitzgerald, Erin McCarthy, Prachi Nakashe, Amin R. Mazloom, Eyad Almasri, Graham McLennan, Daniel S. Grosu, Marcia Eisenberg, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (11): 2274–2279.
https://doi.org/10.1158/1535-7163.MCT-20-1066
Published: 01 November 2021
View article titled, Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
Open the PDF for Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible in another window
Journal Articles

Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients

Free
Taylor J. Jensen, Aaron M. Goodman, Shumei Kato, Christopher K. Ellison, Gregory A. Daniels, Lisa Kim, Prachi Nakashe, Erin McCarthy, Amin R. Mazloom, Graham McLennan, Daniel S. Grosu, Mathias Ehrich, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (2): 448–458.
https://doi.org/10.1158/1535-7163.MCT-18-0535
Published: 04 February 2019
View article titled, Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients
Open the PDF for Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Free
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P. Patel, Garrett M. Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (11): 2598–2608.
https://doi.org/10.1158/1535-7163.MCT-17-0386
Published: 01 November 2017
View article titled, Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Open the PDF for Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

Free
Maria Schwaederle, Barbara A. Parker, Richard B. Schwab, Gregory A. Daniels, David E. Piccioni, Santosh Kesari, Teresa L. Helsten, Lyudmila A. Bazhenova, Julio Romero, Paul T. Fanta, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (4): 743–752.
https://doi.org/10.1158/1535-7163.MCT-15-0795
Published: 05 April 2016
View article titled, Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
Open the PDF for Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience in another window
Includes: Supplementary data
Journal Articles

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients

Free
Maria Schwaederle, Gregory A. Daniels, David E. Piccioni, Paul T. Fanta, Richard B. Schwab, Kelly A. Shimabukuro, Barbara A. Parker, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (6): 1488–1494.
https://doi.org/10.1158/1535-7163.MCT-14-1061
Published: 04 June 2015
View article titled, On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients
Open the PDF for On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients in another window
Includes: Supplementary data